Table 3.
Number of Normal and Endometriosis Patients According to the Intensity of IL-1RII Luminal Immunostaining in the Glands and Surface Epithelium
| Glands and surface epithelium intensity of staining | P value | ||||
|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | ||
| Controls | 7 | 10 | 16 | 6 | |
| Endometriosis (total) | 37 | 8 | 3 | 6 | 10−6* |
| Stage I | 17 | 3 | 1 | 2 | 0.0006* |
| Stage II | 11 | 3 | 0 | 2 | 0.0015* |
| Stage III–IV | 9 | 2 | 2 | 2 | 0.0360* |
| Fertile | 16 | 4 | 0 | 4 | 0.0010* |
| Infertile | 21 | 4 | 3 | 2 | 4× 10−5* |
| Controls | |||||
| Proliferative phase | 5 | 2 | 9 | 2 | |
| Secretory phase | 2 | 8 | 7 | 4 | 0.1370† |
| Endometriosis | |||||
| Proliferative phase | 13 | 2 | 3 | 4 | |
| Secretory phase | 24 | 6 | 0 | 2 | 0.0590† |
| Proliferative phase | |||||
| Control | 5 | 2 | 9 | 2 | |
| Endometriosis | 13 | 2 | 3 | 4 | 0.0760 |
| Secretory phase | |||||
| Control | 2 | 8 | 7 | 4 | |
| Endometriosis | 24 | 6 | 0 | 2 | 8× 10−7* |
*Comparison with controls; only significant P values were corrected by the Bonferroni procedure.
†Comparison of the proliferative phase with the secretory phase.